Latest action: Referred to the House Committee on Foreign Affairs.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Enhances U.S. biotechnology expertise and international diplomatic cooperation in biotech fields.
The problem
The U.S. faces competition in biotechnology globally. International cooperation in biotech research is limited. The country needs stronger diplomatic ties around scientific innovation.
The proposal
The bill establishes programs to improve biotechnology expertise and strengthen diplomatic relationships with other nations through biotech collaboration and exchange initiatives.
The impact
Scientists, diplomats, and biotech companies gain new collaboration opportunities. International partnerships in research expand. U.S. global biotechnology leadership may strengthen.
Enhanced biotech expertise and international partnerships help the U.S. compete globally in biotechnology innovation. This could position America as a biotech leader and attract investment in the sector.
International diplomatic efforts around biotechnology encourage researchers to work together across borders. This could accelerate discoveries and solve problems faster through shared knowledge.
Science and technology cooperation can build stronger relationships between nations. Biotech partnerships create positive channels for dialogue and mutual benefit between countries.
Coordinated international efforts can fund larger, more ambitious biotech research projects. This may lead to breakthroughs in medicine, agriculture, and other important fields.
Sharing biotechnology knowledge internationally could expose sensitive research or dual-use technologies. There are concerns about technology transfer to countries with different interests or standards.
The bill does not specify how programs will be funded or what the cost will be. This makes it difficult to assess the true financial impact on taxpayers.
Without an official summary, the specific mechanisms and goals of these programs are unclear. This makes it hard to evaluate whether the approach will actually work.
Different countries have different rules for biotech research and products. International collaboration could create confusion or conflicts over safety and ethics standards.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Other bills in this policy area
HR 10671
Securing Our Critical Infrastructure Act
HR 10695
United States Submarine Cable Security Policy Act of 2026
HR 7022
Mystic Alerts Act
S 5668
Methane Monitoring Science Act of 2026
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.